Delek Group’s Biogen BIIB Stock Holding History

Delek Group’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-25,000	Closed	-$7.72M	–	210
2018 Q4	$7.72M	Hold	25,000	–	–	0.35%	98
2018 Q3	$8.78M	Sell	25,000 -14,967	-37%	-$5.15M	0.37%	100
2018 Q2	$11.6M	Buy	39,967 +4,400	+12%	+$1.24M	0.5%	72
2018 Q1	$9.75M	Sell	35,567 -5,000	-12%	-$1.55M	0.5%	76
2017 Q4	$12.9M	Buy	+40,567	New	+$13M	0.69%	43

Other funds holding BIIB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Delek Group's BIIB Position: Q1 2019 in Review

Delek Group sold out of Biogen (BIIB) in Q1 2019, closing a stake of 25,000 shares — an estimated $7.72M sold.

Delek Group first reported a position in BIIB in Q4 2017 and held it in 5 quarters. The position peaked at $12.9M in Q4 2017. 1,085 funds tracked by Wall St. Rank hold BIIB as of Q1 2019.

Delek Group reported no remaining Biogen position as of Q1 2019 after selling out during the quarter.
Delek Group sold 25,000 Biogen shares in Q1 2019, an estimated $7.72M.
Delek Group first reported a position in Biogen in Q4 2017 and held it in 5 quarters.
Delek Group's Biogen position peaked at $12.9M in Q4 2017.
1,085 funds tracked by Wall St. Rank held Biogen as of Q1 2019.

Based on Delek Group's 13F filing for Q1 2019, filed 13 May 2019.